New Horizon Health (HKSE:06606) Change In Payables And Accrued Expense : HK$0 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is New Horizon Health Change In Payables And Accrued Expense?

New Horizon Health's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2023 was HK$0 Mil. It means New Horizon Health's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Jun. 2023 .

New Horizon Health's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was HK$0 Mil. It means New Horizon Health's Accounts Payable & Accrued Expense stayed the same from Dec. 2021 to Dec. 2022 .

New Horizon Health Change In Payables And Accrued Expense Historical Data

The historical data trend for New Horizon Health's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Horizon Health Change In Payables And Accrued Expense Chart

New Horizon Health Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Payables And Accrued Expense

New Horizon Health Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial				-	-	-	-	-

New Horizon Health Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

New Horizon Health Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of New Horizon Health's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

New Horizon Health (HKSE:06606) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

6YZ:Germany

Address

400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052

Website

https://ir.newhorizonbio.com

New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.

New Horizon Health (HKSE:06606) Headlines

No Headlines